Results 61 to 70 of about 9,419,656 (260)

Safety and feasibility of platelet rich fibrin matrix injections for treatment of common urologic conditions [PDF]

Investigative and Clinical Urology, 2018
Purpose: Autologous platelet rich plasma (PRP) is used increasingly in a variety of settings. PRP injections have been used for decades to improve angiogenesis and wound healing.
Ethan L Matz, Amy M Pearlman, Ryan P Terlecki   +2 more
doaj   +1 more source

Tacrolimus rescue therapy for renal allograft rejection - Five-year experience [PDF]

, 1997
Over the 5 year period from 7/14/1989 until 5/24/1994, we have attempted graft salvage with tacrolimus conversion in a total of 169 patients (median age 33 years, range 2-75 years) with ongoing rejection on baseline CsA immunosuppression after failure of
Demetris, AJ, Fung, JJ, Gritsch, HA, Jordan, ML, McCauley, J, McMichael, J, Naraghi, R, Randhawa, P, Scantlebury, VP, Shapiro, R, Smith, D, Starzl, TE, Vivas, CA   +12 more
core   +1 more source

Genitourinary Cancer Care in Low- and Middle-Income Countries: Disparities in Incidence and Access to Care

Société Internationale d’Urologie Journal
Despite the considerable global burden of urologic malignancies, Low- and middle-income countries (LMICs) often encounter significant challenges in caring for patients with urologic malignancies.
Kanha Shete, Joshua Ghoulian, Brian Hu, Muhannad Alsyouf   +3 more
doaj   +1 more source

Valproic Acid-induced Priapism In A Child

The Journal of Pediatric Academy, 2021
A complete or partial involuntary erection that occurs in absence of a sexual stimulation and lasts longer than four hours is defined as priapism. Etiology usually includes sickle cell disease or hematologic malignancies.
Esra Türe, Abdullah Yazar, Fatih Akın, Ahmet Osman Kılıç   +3 more
doaj  

Barnes Hospital Bulletin [PDF]

, 1986
https://digitalcommons.wustl.edu/bjc_barnes_bulletin/1244/thumbnail ...

core   +1 more source

Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives

Cancers
Simple Summary This research examines how the loss of the Y chromosome (LoY) in men may contribute to the development and progression of certain cancers, particularly in the urinary system.
P. Russo, F. P. Bizzarri, G. Filomena, Filippo Marino, R. Iacovelli, C. Ciccarese, Luigi Boccuto, M. Ragonese, F. Gavi, Francesco Rossi, C. Savoia, P. Suraci, Roberto Falabella, S. Pandolfo, L. Napolitano, C. Leoni, V. Trevisan, G. Palermo, M. Racioppi, Emilio Sacco, Stijn Muselaers, N. Foschi   +21 more
semanticscholar   +1 more source

Advances in sarcopenia and urologic disorders

Frontiers in Nutrition
Sarcopenia is a loss of muscle strength, muscle mass, and function that can increase a patient’s risk of injury, illness, and can even severely impair quality of life and increase a patient’s risk of death.
Tonglei Zhao, Weipu Mao, Weipu Mao, Weipu Mao, Mingjin Hu, Qingyang Yu, Xinyang Peng, Jie Ji, Jianguo Qiu, Jianping Wu   +9 more
doaj   +1 more source

Surgical management for upper tract transitional cell carcinoma [PDF]

, 2008
This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2008, Issue 4. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic
Cohen, Nicholas P., McClinton, Samuel, N'Dow, James M. O., Nabi, Ghulam, Rai, Bhavan Prasad, Shelley, Mike   +5 more
core   +3 more sources

Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021

Military Medical Research
Background The burden of common urologic diseases, including benign prostatic hyperplasia (BPH), urinary tract infections (UTI), urolithiasis, bladder cancer, kidney cancer, and prostate cancer, varies both geographically and within specific regions.
Hao Zi, Meng-Yang Liu, Li-Sha Luo, Qiao Huang, Peng-Cheng Luo, Hang-Hang Luan, Jiao Huang, Dan-Qi Wang, Yong-Bo Wang, Yuan-Yuan Zhang, Ren-Peng Yu, Yi-Tong Li, Hang Zheng, Tong-Zu Liu, Yu Fan, Xian-Tao Zeng   +15 more
doaj   +1 more source

Neoadjuvant Chemotherapy Use in Bladder Cancer: A Survey of Current Practice and Opinions

Advances in Urology, 2014
Objectives. Level 1 evidence supports the use of neoadjuvant chemotherapy (NAC) to improve overall survival in muscle invasive bladder cancer; however utilization rates remain low.
N. G. Cowan, Y. Chen, T. M. Downs, B. H. Bochner, A. B. Apolo, M. P. Porter, J. C. La Rochelle, C. L. Amling, T. M. Koppie   +8 more
doaj   +1 more source